Kelly L.

Director, Development at Pulmonary Fibrosis Foundation

Kelly L. is an experienced development professional currently serving as the Manager of Development at the Pulmonary Fibrosis Foundation since October 2022. Prior to this role, Kelly L. worked at Rush University Medical Center as the Manager of Events & Appeals with The Woman's Board from December 2019 to October 2022, successfully managing fundraising events that raised $300,000-$400,000 annually. From February 2016 to November 2019, Kelly L. held the position of Volunteer/Events Coordinator at Vision Forward Association, coordinating events that contributed over $200,000 towards annual goals and overseeing a large volunteer base. Earlier in the career, Kelly L. served as the Volunteer Coordinator at Prevent Blindness Wisconsin, where responsibilities included managing community volunteer groups and a preschool reading program. Kelly L. holds a Bachelor of Arts in Psychology from DePaul University.

Location

Chicago, United States

Links

Previous companies


Org chart


Teams


Offices


Pulmonary Fibrosis Foundation

We imagine a world without pulmonary fibrosis. The Pulmonary Fibrosis Foundation is focused on our mission to act as the trusted resource for all who are affected by this disease. Our signature programs include: PFF Care Center Network PFF Patient Registry PFF Patient Communication Center PFF Ambassador Program An international network of support groups and online communities The PFF Summit Comprehensive disease education materials Our expert Medical Advisory Board and the biennial PFF Summit allow us to maintain an ongoing dialogue with physicians, researchers, industry representatives, and the patient community. This creates a collaborative environment that will help us achieve many of our goals. Our peer-reviewed research program supports projects that improve understanding of pulmonary fibrosis and will lead to successful therapies. We have developed significant relationships with industry partners and upheld our position as the honest broker to inform those affected by pulmonary fibrosis of important scientific breakthroughs.


Employees

11-50

Links